Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antidepressants noncompetitively inhibit nicotinic acetylcholine receptor function.

J D Fryer1, R J Lukas

  • 1Division of Neurobiology, Barrow Neurological Institute, Phoenix, Arizona 85013, USA.

Journal of Neurochemistry
|February 26, 1999
PubMed
Summary

Four antidepressants, including sertraline and venlafaxine, acutely block human and chick nicotinic acetylcholine receptors (nAChRs). These findings suggest nAChR subtypes may be therapeutic targets for treating depression.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Exercise training-induced modification of the gut microbiota persists after microbiota colonization and attenuates the response to chemically-induced colitis in gnotobiotic mice.

Gut microbes·2017
Same author

Lipocalin-2 protects the brain during inflammatory conditions.

Molecular psychiatry·2017
Same author

Progressive dopaminergic alterations and mitochondrial abnormalities in LRRK2 G2019S knock-in mice.

Neurobiology of disease·2015
Same author

Roles of nicotinic acetylcholine receptor β subunit cytoplasmic loops in acute desensitization and single-channel features.

Neuroscience·2014
Same author

Differential regulation of nicotinic acetylcholine receptor expression by human TE671/RD cells following second messenger modulation and sodium butyrate treatments.

Molecular and cellular neurosciences·2009
Same author

Differential sensitivity of phosphoinositide metabolism to sodium fluoride and carbachol treatments in PC12 cells.

Molecular and cellular neurosciences·2009

Area of Science:

  • Neuroscience
  • Pharmacology
  • Molecular Biology

Background:

  • Nicotinic acetylcholine receptors (nAChRs) are crucial for nervous system signaling.
  • Antidepressants like fluoxetine are known to affect nAChRs.

Purpose of the Study:

  • To investigate the acute effects of sertraline, paroxetine, nefazodone, and venlafaxine on specific human and chick nAChR subtypes.
  • To confirm the nAChR blocking effects of fluoxetine.

Main Methods:

  • Utilized 86Rb+ efflux assays to measure the function of human muscle-type nAChR, human autonomic nAChR, and chick mutant alpha7-nAChR.
  • Tested the effects of four selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) on nAChR activity.

Main Results:

Related Experiment Videos

  • Sertraline, paroxetine, nefazodone, and venlafaxine demonstrated functional blockade of human muscle-type and autonomic nAChRs at low to intermediate micromolar concentrations.
  • Blockade of chick V274T mutant alpha7-nAChR occurred at intermediate to high micromolar concentrations.
  • The observed blockade was insurmountable, indicating noncompetitive inhibition of nAChR function.

Conclusions:

  • The tested antidepressants noncompetitively inhibit human and chick nAChR subtypes.
  • nAChR subtypes in the brain represent potential therapeutic targets for antidepressant medications and may be implicated in clinical depression.